Track your omega-3 index once a year
Omega-3 insufficiency is extremely common, and a blood test makes supplementation objective instead of a guess. Measure your omega-3 index annually and aim for a value above 8% (a 9–11% target), so you can confirm your intake is actually moving the number rather than assuming it is.
This page isn't typically flagged for the selected profile — shown because you opened it directly.
Dietary omega-3 (EPA and DHA) intake is low in a large share of the population, and these fats matter for neuronal membranes and brain function — relevant for neurodivergent people whose attention, mood and sleep are already stretched. The problem with supplementing blindly is that you can’t feel your blood level, so it’s easy to spend on capsules that don’t move the number.
The omega-3 index is a measurable biomarker: the percentage of EPA plus DHA in red-blood-cell membranes. A simple approach is to test it once a year and treat the result as feedback. A common target is a value above 8%, with 9–11% as the goal range; higher values are associated with better cardiovascular and cognitive outcomes. If your number is low, that’s a cue to adjust intake (oily fish or a supplement) and re-test; if it’s already in range, you have evidence rather than hope. Turning a vague ‘I should take fish oil’ into an annual measured loop is what makes the habit honest.
Helps with
Resources & links
1 sourceWhat the research says
Scientific grade verified against the literature. No entries = no direct studies (graded from mechanism/experience).
- Omega-3 fatty acid and ADHD: Blood level analysis and meta-analytic extension of supplementation trialsmeta-analysis · 2014
- Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trialsmeta-analysis · 2023
- Omega-3 fatty acids for autism spectrum disorders (ASD) (Cochrane Review)meta-analysis · 2011
- Urinary Metabolite Profiling to Non-Invasively Monitor the Omega-3 Index: An Exploratory Secondary Analysis of a Randomized Clinical Trial in Young AdultsRCT · 2023